Evidence map›Paper›PMID 34474809›Full record

ArticleESMO open2021

Erratum to 'Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial': [ESMO Open Volume 6, Issue 3, June 2021, 100101].

T K Choueiri, J Larkin, S Pal, R J Motzer, B I Rini, B Venugopal, B Alekseev, H Miyake, G Gravis, M A Bilen and 9 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in ESMO open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 68% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 13 institutions in 6 countries.

T K ChoueiriDepartment of Medical Oncology, The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, USA. Electronic address: toni_choueiri@dfci.harvard.edu.
J LarkinRenal and Skin Units, The Royal Marsden NHS Foundation Trust, Chelsea, London, UK.
S PalDepartment of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, USA.
R J MotzerDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
B I RiniDepartment of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, USA.
B VenugopalInstitute of Cancer Sciences, University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, Scotland, UK.
B AlekseevP. Hertsen Moscow Oncology Research Institute, Moscow, Russia.
H MiyakeDepartment of Urology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
G GravisDepartment of Medical Oncology, Institut Paoli-Calmettes, Aix-Marseille Université, Inserm, CNRS, CRCM, Marseille, France.
M A BilenDepartment of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, USA.
S HariharanOncology, Pfizer, New York, USA.
A ChudnovskyOncology, Pfizer, Cambridge, USA.
K A ChingComputational Biology, Pfizer, San Diego, USA.
X J MuComputational Biology, Pfizer, San Diego, USA.
M MarianiImmuno-Oncology, Pfizer, Milan, Lombardia, Italy.
P B RobbinsTranslational Oncology, Pfizer, San Diego, USA.
B HuangBiostatistics, Pfizer, Groton, USA.
A di PietroImmuno-Oncology, Pfizer, Milan, Lombardia, Italy.
L AlbigesDepartment of Medical Oncology, Institut Gustave Roussy, Villejuif, France.
Pfizer (United States) · USPfizer (Italy) · ITCentre National de la Recherche Scientifique · FRCity of Hope · USDana-Farber Cancer Institute · USEmory University · USHamamatsu University School of Medicine · JPInstitut Gustave Roussy · FRMemorial Sloan Kettering Cancer Center · USP.A. Hertzen Moscow Oncology Research Institute · RURoyal Marsden NHS Foundation Trust · GBUniversity of Glasgow · GBVanderbilt University Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34474809
PMCPMC8411062
OpenAlexW4233140710

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.